Gary J. Bridger's most recent trade in X4 Pharmaceuticals Inc was a trade of 110,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| X4 Pharma Inc | Gary J. Bridger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2026 | 110,000 | 0 | - | - | Stock Option (right to buy) | |
| X4 Pharma Inc | Gary J. Bridger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 1,500 | 4,722 (0%) | 0% | 0 | Common Stock | |
| X4 Pharma Inc | Gary J. Bridger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 45,000 | 96,667 (0%) | 0% | 0 | Common Stock | |
| X4 Pharma Inc | Gary J. Bridger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 6,667 | 6,667 (0%) | 0% | 0 | Common Stock | |
| X4 Pharma Inc | Gary J. Bridger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 6,000 | 6,000 | - | - | Stock Option (right to buy) |